DNAJC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.32019958801288E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.7938999998306E-07 |
Normal-vs-Stage2 |
3.956200E-04 |
Normal-vs-Stage3 |
3.94159999994592E-06 |
Normal-vs-Stage4 |
4.17959999943207E-09 |
Stage1-vs-Stage2 |
4.487800E-01 |
Stage1-vs-Stage3 |
3.621200E-01 |
Stage1-vs-Stage4 |
1.715840E-03 |
Stage2-vs-Stage3 |
9.645000E-01 |
Stage2-vs-Stage4 |
7.204300E-02 |
Stage3-vs-Stage4 |
2.646300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.25760002411823E-09 |
Normal-vs-AfricanAmerican |
3.67620000000235E-05 |
Normal-vs-Asian |
1.000570E-01 |
Caucasian-vs-AfricanAmerican |
4.964200E-01 |
Caucasian-vs-Asian |
3.996000E-01 |
AfricanAmerican-vs-Asian |
5.741800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.2751000517427E-09 |
Normal-vs-Female |
1.1039000047397E-08 |
Male-vs-Female |
6.912600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.076280E-02 |
Normal-vs-Age(41-60Yrs) |
5.97699999493884E-08 |
Normal-vs-Age(61-80Yrs) |
2.93439994525357E-09 |
Normal-vs-Age(81-100Yrs) |
5.001800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.571800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.560000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.764400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.615400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.972000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.480800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.382970E-03 |
Normal-vs-Grade 2 |
7.740200003159E-08 |
Normal-vs-Grade 3 |
1.61639999995966E-06 |
Normal-vs-Grade 4 |
1.54470000124363E-08 |
Grade 1-vs-Grade 2 |
7.149600E-01 |
Grade 1-vs-Grade 3 |
6.060800E-01 |
Grade 1-vs-Grade 4 |
3.317000E-01 |
Grade 2-vs-Grade 3 |
6.377400E-01 |
Grade 2-vs-Grade 4 |
6.461600E-03 |
Grade 3-vs-Grade 4 |
3.182200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.13489999964811E-07 |
Normal-vs-ccB subtype |
2.36380000018244E-07 |
ccA subtype-vs-ccB subtype |
3.704000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.60340000165959E-08 |
Normal-vs-N1 |
1.346340E-02 |
N0-vs-N1 |
1.726790E-01 |
|
|